Cargando…

Disease progression and costs at the 3‐year follow‐up of the GERAS‐US study

INTRODUCTION: GERAS‐US prospectively characterized clinical and economic outcomes of early symptomatic Alzheimer's disease (AD). Societal cost changes were examined in amyloid‐positive patients with mild cognitive impairment due to AD (MCI) and mild dementia due to AD (MILD). METHODS: Cognition...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chandler, Julie M., Rentz, Dorene M., Zagar, Anthony, Kim, Yongin, Schwartz, Ronald L., Fillit, Howard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10113935/ https://www.ncbi.nlm.nih.gov/pubmed/37091310 http://dx.doi.org/10.1002/dad2.12430

Ejemplares similares

Costs of Early Stage Alzheimer’s Disease in the United States: Cross-Sectional Analysis of a Prospective Cohort Study (GERAS-US)(1)
por: Robinson, Rebecca L., et al.
Publicado: (2020)

Observation of Patient and Caregiver Burden Associated with Early Alzheimer’s Disease in the United States: Design and Baseline Findings of the GERAS-US Cohort Study(1)
por: Robinson, Rebecca L., et al.
Publicado: (2019)

Clinical and Economic Assessment in Early-Stage Dementia by Severity and Amyloid-β Status: A 5-Year Retrospective Claims Study of GERAS-US Patients
por: Chandler, Julie, et al.
Publicado: (2023)

Disease Progression in Mild Dementia due to Alzheimer Disease in an 18-Month Observational Study (GERAS): The Impact on Costs and Caregiver Outcomes
por: Jones, Roy W., et al.
Publicado: (2017)

Development of GERAS DANcing for Cognition and Exercise (DANCE): a feasibility study
por: Hewston, Patricia, et al.
Publicado: (2022)

How to deal with missing longitudinal data in cost of illness analysis in Alzheimer’s disease—suggestions from the GERAS observational study
por: Belger, Mark, et al.
Publicado: (2016)

Validating Use of Technology for Cognitive Test Assessment
por: Rentz, Dorene M.
Publicado: (2016)

Role of the gerA operon in L-alanine germination of Bacillus licheniformis spores
por: Løvdal, Irene S, et al.
Publicado: (2012)

CBCT Assessment of Ethmoid Roof Variations through Keros, Gera, and TMS Classifications
por: Mahdian, Mina, et al.
Publicado: (2022)

L-alanine-induced germination in Bacillus licheniformis -the impact of native gerA sequences
por: Madslien, Elisabeth H, et al.
Publicado: (2014)

A prospective, multicentre study to assess frailty in elderly patients with leg ulcers (GERAS study)
por: Zorge, Nadja E., et al.
Publicado: (2022)

Costs and Resource Use Associated with Community-Dwelling Patients with Alzheimer’s Disease in Japan: Baseline Results from the Prospective Observational GERAS-J Study
por: Nakanishi, Miharu, et al.
Publicado: (2020)

Demonstration of Clinical Meaningfulness of the Integrated Alzheimer’s Disease Rating Scale (iADRS): Association Between Change in iADRS Scores and Patient and Caregiver Health Outcomes
por: Wessels, Alette M., et al.
Publicado: (2022)

Resource utilisation, costs and clinical outcomes in non-institutionalised patients with Alzheimer’s disease: 18-month UK results from the GERAS observational study
por: Lenox-Smith, Alan, et al.
Publicado: (2016)

Commentary on Composite cognitive and functional measures for early stage Alzheimer's disease trials
por: Rentz, Dorene M., et al.
Publicado: (2020)

Caregiver Burden in Alzheimer's Disease: Differential Associations in Adult-Child and Spousal Caregivers in the GERAS Observational Study
por: Reed, Catherine, et al.
Publicado: (2014)

Potential cost savings to be made by slowing cognitive decline in mild Alzheimer’s disease dementia using a model derived from the UK GERAS observational study
por: Lenox-Smith, Alan, et al.
Publicado: (2018)

Positions 299 and 302 of the GerAA subunit are important for function of the GerA spore germination receptor in Bacillus subtilis
por: Grela, Anna, et al.
Publicado: (2018)

Livestock farmers' perception of climate change and adaptation strategies in the Gera district, Jimma zone, Oromia Regional state, southwest Ethiopia
por: Abazinab, Hassen, et al.
Publicado: (2022)

The Geras virtual frailty rehabilitation program to build resilience in older adults with frailty during COVID-19: a randomized feasibility trial
por: Okpara, Chinenye, et al.
Publicado: (2023)

Integrated Alzheimer's Disease Rating Scale: Clinically meaningful change estimates
por: Wessels, Alette M., et al.
Publicado: (2022)

Methodological challenges in assessing the impact of comorbidities on costs in Alzheimer’s disease clinical trials
por: Kahle-Wrobleski, Kristin, et al.
Publicado: (2014)

Potential Cost-Effectiveness of US-Guided FNAC in Melanoma Patients as a Primary Procedure and in Follow-Up
por: van Akkooi, Alexander C. J., et al.
Publicado: (2009)

Web Camera Based Eye Tracking to Assess Visual Memory on a Visual Paired Comparison Task
por: Bott, Nicholas T., et al.
Publicado: (2017)

Optimizing the preclinical Alzheimer's cognitive composite with semantic processing: The PACC5
por: Papp, Kathryn V., et al.
Publicado: (2017)

Determining initial and follow-up costs of cardiovascular events in a US managed care population
por: Chapman, Richard H, et al.
Publicado: (2011)

Burden of Migraine in Japan: Results of the ObserVational Survey of the Epidemiology, tReatment, and Care Of MigrainE (OVERCOME [Japan]) Study
por: Matsumori, Yasuhiko, et al.
Publicado: (2021)

Potential Unmet Needs in Acute Treatment of Migraine in Japan: Results of the OVERCOME (Japan) Study
por: Takeshima, Takao, et al.
Publicado: (2022)

Outcomes and Factors Associated with Insufficient Effectiveness of Acute Treatments of Migraine in Japan: Results of the ObserVational survey of the Epidemiology, tReatment, and Care Of MigrainE (OVERCOME [Japan]) Study
por: Hirata, Koichi, et al.
Publicado: (2023)

Promising developments in neuropsychological approaches for the detection of preclinical Alzheimer’s disease: a selective review
por: Rentz, Dorene M, et al.
Publicado: (2013)

Progress in novel cognitive enhancers for cognitive aging and Alzheimer’s disease
por: Shineman, Diana W, et al.
Publicado: (2013)

Representativeness of European clinical trial populations in mild Alzheimer’s disease dementia: a comparison of 18-month outcomes with real-world data from the GERAS observational study
por: Reed, Catherine, et al.
Publicado: (2018)

Undernutrition and its associated factors among children aged 6 to 59 months in Menz Gera Midir district, Northeast Ethiopia: A community-based cross-sectional study
por: Engidaye, Getabalew, et al.
Publicado: (2022)

Role of serum S100B and PET-CT in follow-up of patients with cutaneous melanoma
por: Peric, Barbara, et al.
Publicado: (2011)

Relation of modifiable lifestyle and mood factors to cognitive concerns among participants and their study partners in the A4 screen data
por: Reynolds, Gretchen, et al.
Publicado: (2023)

Novel strategies for the prevention of dementia from Alzheimer's disease
por: Shineman, Diana W., et al.
Publicado: (2009)

Meeting the unique challenges of drug discovery for neurodegenerative diseases
por: Shineman, Diana W, et al.
Publicado: (2009)

Face Name Associative Memory Exam and biomarker status in the ARMADA study: Advancing reliable measurement in Alzheimer's disease and cognitive aging
por: Rentz, Dorene M., et al.
Publicado: (2023)

Multiple markers contribute to risk of progression from normal to mild cognitive impairment
por: Rabin, Jennifer S., et al.
Publicado: (2020)

Evolution of Costs of Inflammatory Bowel Disease over Two Years of Follow-Up
por: van der Valk, Mirthe E., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_mvpk5t8vobcg6ef9g7osqei9ij